We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+1.97%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$32.2B
AUM Growth
+$1.15B
Cap. Flow
+$886M
Cap. Flow %
2.75%
Top 10 Hldgs %
14.34%
Holding
3,060
New
26
Increased
2,468
Reduced
355
Closed
63

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$23.3M
2
XOM icon
ExxonMobil
XOM
+$22.8M
3
AAPL icon
Apple
AAPL
+$21.5M
4
WFC icon
Wells Fargo
WFC
+$19.8M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$17.3M

Sector Composition

Rank Sector Weight
1 Technology 14.4%
2 Financials 14.39%
3 Healthcare 13.67%
4 Industrials 10.84%
5 Consumer Discretionary 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LFCR icon
2301
Lifecore Biomedical
LFCR
$167M
$440K ﹤0.01%
41,925
+3,300
+9% +$36.2K
NGS icon
2302
Natural Gas Services Group
NGS
$472M
$440K ﹤0.01%
20,323
+1,885
+10% +$35.9K
ABB
2303
DELISTED
ABB Ltd
ABB
$440K ﹤0.01%
22,660
WW
2304
DELISTED
WW International
WW
$439K ﹤0.01%
30,218
+225
+0.8% +$3.06K
AUD
2305
DELISTED
Audacy, Inc.
AUD
$439K ﹤0.01%
41,474
+3,660
+10% +$38.9K
CHGG icon
2306
Chegg
CHGG
$115M
$438K ﹤0.01%
98,245
+7,030
+8% +$35.7K
LGIH icon
2307
LGI Homes
LGIH
$1.43B
$438K ﹤0.01%
18,073
+1,535
+9% +$34.2K
SGMO
2308
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$438K ﹤0.01%
72,403
+420
+0.6% +$2.52K
PERY
2309
DELISTED
Perry Ellis International Inc
PERY
$438K ﹤0.01%
23,769
+2,105
+10% +$38.4K
ACRE
2310
Ares Commercial Real Estate
ACRE
$261M
$437K ﹤0.01%
39,939
+3,825
+11% +$39.8K
GLOB icon
2311
Globant
GLOB
$1.66B
$436K ﹤0.01%
14,144
+45
+0.3% +$1.36K
HURC icon
2312
Hurco Companies Inc
HURC
$142M
$436K ﹤0.01%
13,213
+920
+7% +$25.2K
AMPH icon
2313
Amphastar Pharmaceuticals
AMPH
$877M
$435K ﹤0.01%
36,285
+1,495
+4% +$17.6K
QTWO icon
2314
Q2 Holdings
QTWO
$3.97B
$435K ﹤0.01%
18,109
-35
-0.2% -$751
CACQ
2315
DELISTED
Caesars Acquisition Company
CACQ
$435K ﹤0.01%
71,062
+7,170
+11% +$40.3K
MESG
2316
DELISTED
XURA INC COM (DE)
MESG
$434K ﹤0.01%
22,077
+480
+2% +$9.85K
AD
2317
Array Digital Infrastructure
AD
$3.06B
$433K ﹤0.01%
9,480
+250
+3% +$9.73K
SFE
2318
DELISTED
Safeguard Scientifics, Inc.
SFE
$433K ﹤0.01%
32,710
+3,100
+10% +$39K
INWK
2319
DELISTED
InnerWorkings, Inc.
INWK
$433K ﹤0.01%
54,471
+4,150
+8% +$29.1K
SCNB
2320
DELISTED
Suffolk Bancorp
SCNB
$433K ﹤0.01%
17,170
+1,750
+11% +$44.6K
EPZM
2321
DELISTED
Epizyme, Inc
EPZM
$432K ﹤0.01%
35,679
+8,045
+29% +$81.4K
VSEC icon
2322
VSE Corp
VSEC
$6.05B
$431K ﹤0.01%
12,700
+1,390
+12% +$42.2K
LBY
2323
DELISTED
Libbey, Inc.
LBY
$431K ﹤0.01%
23,186
+175
+0.8% +$3.07K
SN
2324
DELISTED
Sanchez Energy Corporation
SN
$431K ﹤0.01%
78,427
+7,440
+10% +$28.8K
CTRN icon
2325
Citi Trends
CTRN
$606M
$430K ﹤0.01%
24,109
+2,245
+10% +$42K

Similar funds

RhumbLine Advisers's Q1 2016 Portfolio in Review

As of Q1 2016, RhumbLine Advisers held 3,060 positions worth $32.2B, up 3.7% from $31.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q1 2016: portfolio turnover was 2.9%. RhumbLine Advisers opened 26 new positions and exited 63, leaving the 3,060-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2016 buy was Willis Towers Watson: 89,353 shares worth $10.6M.
  • RhumbLine Advisers added most to Broadcom in Q1 2016, an estimated $23.3M increase.
  • RhumbLine Advisers's biggest Q1 2016 reduction was Chubb, cutting an estimated $13.7M.
  • RhumbLine Advisers fully exited BROADCOM CORP CL-A in Q1 2016, selling an estimated $43M.
  • RhumbLine Advisers's ten largest holdings make up 14% of its $32.2B portfolio in Q1 2016.
  • RhumbLine Advisers opened 26 new positions and closed 63 in Q1 2016.
  • RhumbLine Advisers's portfolio value rose 3.7% quarter-over-quarter to $32.2B.

Based on RhumbLine Advisers's 13F filing for Q1 2016, filed 2 May 2016.